GC Pharma Receives Complete Response Letter From the U.S. FDA For ‘ALYGLO’
Summary : GC Pharma (KRX:006280) today announced that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug…
Summary : GC Pharma (KRX:006280) today announced that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug…
Summary : Morepen Laboratories Limited has received USFDA approval for its anti-allergy drug fexofinadine hydrochloride Fexofinadine is most widely used, second generation…